Welcome
Here are some key things we think you should know about us before you dive into our documents and data!
We’d love to walk you through our deck
Our Pathway
Grounded in >10 years of innovation in the Vincent Group at University of Oxford, supported by >£3m non-dilutive funding for targeted de-risking and translation research
CEO led market validation with 100 conversations across the chemicals sector before building a technology roadmap and route to market
4 years of intensification and scale up work in dedicated labs, supported by >£3m private investment and >£1m non-dilutive Innovate UK funding
Technology validated in partner kilo-lab and scale up facilities
Currently working on 3 active joint-development projects, with biocatalyst products in >12 customer labs
Hear from our Advisors
Jonathan Tudor, Investor Director, Clean Growth Fund
From his recent article: HydRegen is entering a critical phase of its journey, seeking funding to scale its pilot facilities and expand into commercial partnerships.
For my fellow venture capitalists and impact investors, this represents a rare opportunity to support a company at the intersection of deep tech, sustainability, and industrial transformation.
The potential returns aren’t just financial. HydRegen offers investors a tangible way to contribute to global decarbonisation efforts while positioning themselves as leaders in sustainability.
“This innovation isn’t just about sustainability; it’s also about economics. HydRegen’s process can cut costs for manufacturers by reducing energy consumption and simplifying production workflows. The ability to retrofit existing infrastructure means chemical producers can implement this green technology with minimal disruption—a crucial advantage in an industry resistant to large-scale change.”
Dr Joe de Sousa, NED,
Drug substance manufacturing expert (20+ years' experience)>25 years at Astra Zeneca
“We can’t escape from cost being critical but on top of that there is societal and regulatory demand for more sustainability. The versatility of the HydRegen catalysts is really impressive, and, in addition the specificity makes them really compelling.”
The HydRegen technology is transformative across the chemicals sector, here we talk to Joe specifically about key drivers for adoption in pharmaceutical manufacturing.
This fundraise
We are a knowledge-intensive company, with the potential to deliver cost and carbon savings across 14% of the chemicals sectors.
Our team and advisors have worked across chemical manufacturing, catalyst licensing, regulatory compliance and more, meaning we are well placed to deliver on our ambitious plans.
Right now, we are looking for funding to support growth of our commercial and development teams, to accelerate our impact on this critical sector that underpins >96% of all manufactured goods.
We deliver our customers up to 50% cost saving and 3xCO2e savings, making us a high impact, high growth potential business.
More coming soon!
Do get in touch for more information and to see our deck, or read some of our articles to see how we differentiate ourselves! We suggest this as a good starting point: